RETINAX Trademark

Trademark Overview

On Friday, September 9, 2022, a trademark application was filed for RETINAX with the United States Patent and Trademark Office. The USPTO has given the RETINAX trademark a serial number of 97584443. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Lenz Therapeutics, Inc.. The RETINAX trademark is filed in the Pharmaceutical Products category with the following description:

eye drops; eye drops for the treatment of ophthalmic disorders
retinax

General Information

Serial Number97584443
Word MarkRETINAX
Filing DateFriday, September 9, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and Serviceseye drops; eye drops for the treatment of ophthalmic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLenz Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDel Mar, CA 92014
Party NameLenz Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRancho Santa Fe, CA 92067

Trademark Events

Event DateEvent Description
Tuesday, September 13, 2022NEW APPLICATION ENTERED
Monday, September 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 30, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023SOU EXTENSION 1 FILED
Wednesday, August 30, 2023SOU EXTENSION 1 GRANTED
Friday, September 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2024SOU EXTENSION 2 FILED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 1, 2024SOU EXTENSION 2 GRANTED
Saturday, March 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 3 FILED
Friday, September 20, 2024SOU EXTENSION 3 GRANTED

Related Keywords

retinax drops disorders treatment ophthalmic